Current Report · Items 5.02 · 8-K
Allurion Technologies, Inc.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 30, 2026, Douglas Hudson, a Class II member of the board of directors (the “Board”) of Allurion Technologies, Inc.…
Filed Jul 7, 2026Accepted Jul 7, 2026, 8:05 AM EDTCIK 1964979Accession 0001193125-26-296918
Company context
Allurion is a pioneer in metabolically healthy weight loss. The Allurion Program is a weight-loss platform that combines the Allurion Smart Capsule, the world’s first and only swallowable, ProcedurelessTM gastric balloon for weight loss, the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor, and manage weight-loss therapy for patients regardless of their treatment plan. The Allurion Smart Capsule is an investigational device in the United States.
Current securities
Historical securities (4)
Registered securities in this filing
Allurion Technologies, Inc. · 8-K · Filed 2026-07-07
As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.
Common stock, par value $0.0001 per share
- Symbol
- ALUR
- Exchange
- NONE
- Classification
- COMMON
Filing context
Context: C_13c70a92-e691-4c21-a497-6ddc39d2ea6a
Dimensions: us-gaap:StatementClassOfStockAxis
Warrants to purchase 0.00378787 shares of common stock, each at an exercise price of $3,037.50 per share of common stock
- Symbol
- ALUR WS
- Exchange
- NONE
- Classification
- WARRANT
Filing context
Context: C_840c341d-9eb8-4cb9-adac-6e0c76af8f8a
Dimensions: us-gaap:StatementClassOfStockAxis
Accession 000119312526296918 · 2 registered-security cover members
Read the exact SEC filing ↗Disclosure sections
Items 5.02Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 30, 2026, Douglas Hudson, a Class II member of the board of directors (the “Board”) of Allurion Technologies, Inc. (the “Company”), notified the Company of his resignation from the Board and position on the Nominating and Corporate Governance Committee of the Board, effective the same day. Mr. Hudson's resignation was not the result of any disagreement with management or the Board or on any matter relating to the Company’s operations, policies or practices.
The Board is currently evaluating which of its directors will replace Mr. Hudson on the Nominating and Corporate Goverance Committee.